E
180 Life Sciences Corp. ATNF
$1.19 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 4.01M 5.05M 3.42M 4.02M 2.97M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 4.80M 5.64M 4.06M 4.52M 3.68M
Operating Income -4.80M -5.64M -4.06M -4.52M -3.68M
Income Before Tax -4.76M -22.69M -21.49M 2.94M 1.56M
Income Tax Expenses -- -942.70K -- -- --
Earnings from Continuing Operations -4.76M -21.74M -21.49M 2.94M 1.56M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -4.76M -21.74M -21.49M 2.94M 1.56M
EBIT -4.80M -5.64M -4.06M -4.52M -3.68M
EBITDA -4.78M -5.60M -4.05M -4.48M -3.65M
EPS Basic -1.27 -9.75 -10.97 1.72 0.92
Normalized Basic EPS -0.79 -1.31 -0.83 1.08 0.57
EPS Diluted -1.27 -9.82 -11.00 1.72 0.92
Normalized Diluted EPS -0.79 -1.31 -0.83 1.08 0.57
Average Basic Shares Outstanding 3.75M 2.23M 1.96M 1.71M 1.70M
Average Diluted Shares Outstanding 3.75M 2.23M 1.96M 1.71M 1.70M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings